Moody, S E
Schinzel, A C
Singh, S
Izzo, F
Strickland, M R
Luo, L
Thomas, S R
Boehm, J S http://orcid.org/0000-0002-6795-6336
Kim, S Y
Wang, Z C
Hahn, W C
Article History
Received: 24 February 2014
Revised: 12 April 2014
Accepted: 18 April 2014
First Online: 9 June 2014
Competing interests
: SEM receives consulting fees from N-of-One Therapeutics. WCH receives consulting fees from Novartis, Blueprint Medicines and Thermo Fisher. The Hahn laboratory receives research support from Novartis. The remaining authors declare no conflict of interest.